Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals

Antigen crosspresentation by human plasmacytoid dendritic cells

Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects

Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag

A dendritic cell-based vaccine for treating HIV infection: background and preliminary results

Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile

Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial

Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells